相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial
Renu R. Bahadoer et al.
LANCET ONCOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23) : a multicentre, randomised, open-label, phase 3 trial
Thierry Conroy et al.
LANCET ONCOLOGY (2021)
Detection of low-frequency DNA variants by targeted sequencing of the Watson and Crick strands
Joshua D. Cohen et al.
NATURE BIOTECHNOLOGY (2021)
Conventional myelosuppressive chemotherapy for non-haematological malignancy disrupts the intestinal microbiome
Lito E. Papanicolas et al.
BMC CANCER (2021)
International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer
Emmanouil Fokas et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Preliminary results of the organ preservation of rectal adenocarcinoma (OPRA) trial.
Julio Garcia-Aguilar et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Evaluation of Circulating Tumor DNA for Methylated BCAT1 and IKZF1 to Detect Recurrence of Stage II/Stage III Colorectal Cancer (CRC)
Benjamin L. Musher et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2020)
Total Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer A Systematic Review and Meta-analysis
Anup Kasi et al.
JAMA NETWORK OPEN (2020)
Australian Utility Weights for the EORTC QLU-C10D, a Multi-Attribute Utility Instrument Derived from the Cancer-Specific Quality of Life Questionnaire, EORTC QLQ-C30
Madeleine T. King et al.
PHARMACOECONOMICS (2018)
Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study
Maxime J. M. van der Valk et al.
LANCET (2018)
Methylation and Gene Expression of BCAT1 and IKZF1 in Colorectal Cancer Tissues
Maher Jedi et al.
CLINICAL MEDICINE INSIGHTS-ONCOLOGY (2018)
Gut microbiota modulation of chemotherapy efficacy and toxicity
James L. Alexander et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors
Shona Hendry et al.
ADVANCES IN ANATOMIC PATHOLOGY (2017)
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
TaChung Yu et al.
CELL (2017)
Host-Microbe Co-metabolism Dictates Cancer Drug Efficacy in C. elegans
Timothy A. Scott et al.
CELL (2017)
Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
Jeanne Tie et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
A Blood Test for Methylated BCAT1 and IKZF1 vs. a Fecal Immunochemical Test for Detection of Colorectal Neoplasia
Erin L. Symonds et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2016)
Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer
J. Tie et al.
ANNALS OF ONCOLOGY (2015)
Evaluation of an assay for methylated BCAT1 and IKZF1 in plasma for detection of colorectal neoplasia
Susanne K. Pedersen et al.
BMC CANCER (2015)
Screening and comorbidity of clinical levels of fear of cancer recurrence
Sebastien Simard et al.
JOURNAL OF CANCER SURVIVORSHIP (2015)
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
R. Salgado et al.
ANNALS OF ONCOLOGY (2015)
A Two-Gene Blood Test for Methylated DNA Sensitive for Colorectal Cancer
Susanne K. Pedersen et al.
PLOS ONE (2015)
Retrospective study of patients (pts) who were managed with Watch and Wait strategy (W&W) after neoadjuvant chemoradiation (NCRT) for Locally Advanced Rectal Cancer (LARC)
Sina Vatandoust et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients
Camila Miranda Lopes-Ramos et al.
BMC MEDICAL GENOMICS (2014)
Local Recurrence After Complete Clinical Response and Watch and Wait in Rectal Cancer After Neoadjuvant Chemoradiation: Impact of Salvage Therapy on Local Disease Control
Angelita Habr-Gama et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study
Jean-Francois Bosset et al.
LANCET ONCOLOGY (2014)
Nonoperative Management of Rectal Cancer With Complete Clinical Response After Neoadjuvant Therapy
James D. Smith et al.
ANNALS OF SURGERY (2012)
Low Anterior Resection Syndrome Score Development and Validation of a Symptom-Based Scoring System for Bowel Dysfunction After Low Anterior Resection for Rectal Cancer
Katrine J. Emmertsen et al.
ANNALS OF SURGERY (2012)
A single-centre experience of chemoradiotherapy for rectal cancer: is there potential for nonoperative management?
R. S. J. Dalton et al.
COLORECTAL DISEASE (2012)
Preoperative Versus Postoperative Chemoradiotherapy for Locally Advanced Rectal Cancer: Results of the German CAO/ARO/AIO-94 Randomized Phase III Trial After a Median Follow-Up of 11 Years
Rolf Sauer et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett's Epithelium
Toshiro Sato et al.
GASTROENTEROLOGY (2011)
Wait-and-See Policy for Clinical Complete Responders After Chemoradiation for Rectal Cancer
Monique Maas et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Magnetic Resonance Imaging-Detected Tumor Response for Locally Advanced Rectal Cancer Predicts Survival Outcomes: MERCURY Experience
Uday B. Patel et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Non-coding RNAs in human disease
Manel Esteller
NATURE REVIEWS GENETICS (2011)
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
M. Herdman et al.
QUALITY OF LIFE RESEARCH (2011)
Rectal Cancer: Primary Staging and Assessment After Chemoradiotherapy
Jessica Evans et al.
SEMINARS IN RADIATION ONCOLOGY (2011)
Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data
Monique Maas et al.
LANCET ONCOLOGY (2010)
Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer
R. N. Whistance et al.
EUROPEAN JOURNAL OF CANCER (2009)
Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche
Toshiro Sato et al.
NATURE (2009)
Circulating mutant DNA to assess tumor dynamics
Frank Diehl et al.
NATURE MEDICINE (2008)
The development and evaluation of a measure to assess cancer survivors' unmet supportive care needs: The CaSUN (Cancer Survivors' Unmet Needs measure)
K. Hodgkinson et al.
PSYCHO-ONCOLOGY (2007)
Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers:: Results of FFCD 9203
Jean-Pierre Gerard et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: Preliminary results - EORTC 22921
JF Bosset et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The development of a validated instrument to evaluate bowel function after sphincter-preserving surgery for rectal cancer
LK Temple et al.
DISEASES OF THE COLON & RECTUM (2005)
Preoperative versus postoperative chemoradiotherapy for rectal cancer
R Sauer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Bladder and sexual dysfunction after mesorectal excision for rectal cancer
A Nesbakken et al.
BRITISH JOURNAL OF SURGERY (2000)